Business Standard

Don’t miss the latest developments in business and finance.

Sun Pharma to acquire 100% stake in Antibe Therapeutics Inc.

Bs_logoImage
Last Updated : Jan 16 2025 | 2:50 PM IST
TARO Pharmaceuticals Inc., a subsidiary of Sun Pharmaceutical Industries, has entered into an agreement with Antibe Therapeutics Inc., Canada, pursuant to which Sun Pharma has agreed to acquire 100% stake in Antibe Therapeutics Inc.

Antibe Therapeutics Inc. (Antibe) is an Ontario, Canada incorporated corporation based in Ontario, Canada. It is a clinical-stage biotechnological company developing novel drugs primarily focusing on reducing pain and inflammation.

Antibe is currently being managed by a court appointed receiver, and the receiver is authorized to carry out the sale of Antibe.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Jan 16 2025 | 2:30 PM IST

Next Story